ORG 13061

Drug Profile

ORG 13061

Latest Information Update: 08 Jan 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Organon
  • Class Antihyperlipidaemics; Dioxoles; Piperidines; Small molecules
  • Mechanism of Action Antioxidants; Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Atherosclerosis

Most Recent Events

  • 08 Jan 2001 Discontinued-Preclinical for Atherosclerosis in France (PO)
  • 17 Oct 1997 A preclinical study has been added to the Ischaemic Heart Disease and Hyperlipidaemia pharmacodynamics sections
  • 06 Oct 1997 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top